Skip to main content
. 2019 Apr 3;15(4):e1006478. doi: 10.1371/journal.pcbi.1006478

Table 1.

List of interactors putatively not affected by pVHL mutations found in patients presenting a specific a VHL phenotype (left). Phosphorylation sites found to be frequently mutated in both renal manifestations of VHL (collectively including RCC, ccRCC, renal cysts) and pheochromocytoma (right).

Conserved interactions Mutated phosphorylation sites
Pheochromocytoma Hemangioblastoma Renal disease & Pheochromocytoma
HSPA4 TP53 AURKA
AKT1 ID2 CSNK2A1
ELAVL1 CHEK2
E2F1 GSK3B
ELOC NEDD8